CD8A and myelodysplastic syndrome: The STAT3/ARG1 pathway also contributes to the suppression of CD8+ T cells induced by MDSCs in MDS; the use of STAT3 inhibitors can partially restore the CD8+ T cell function interfered by the MDSCs derived from MDS [62].